학술논문
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
Document Type
Article
Author
Herbst, Roy S; Arkenau, Hendrik-Tobias; Santana-Davila, Rafael; Calvo, Emiliano; Paz-Ares, Luis; Cassier, Philippe A; Bendell, Johanna; Penel, Nicolas; Krebs, Matthew G; Martin-Liberal, Juan; Isambert, Nicolas; Soriano, Andres; Wermke, Martin; Cultrera, Jennifer; Gao, Ling; Widau, Ryan C; Mi, Gu; Jin, Jin; Ferry, David; Fuchs, Charles S; Petrylak, Daniel P; Chau, Ian
Source
In The Lancet Oncology August 2019 20(8):1109-1123
Subject
Language
ISSN
1470-2045